Menu
GWAS Study

A genome-wide association study identifies six novel risk loci for primary biliary cholangitis.

Qiu F, Tang R, Zuo X et al.

28425483 PubMed ID
GWAS Study Type
8192 Participants
Scroll to explore
Chapter I

Publication Details

Comprehensive information about this research publication

Authors

QF
Qiu F
TR
Tang R
ZX
Zuo X
SX
Shi X
WY
Wei Y
ZX
Zheng X
DY
Dai Y
GY
Gong Y
WL
Wang L
XP
Xu P
ZX
Zhu X
WJ
Wu J
HC
Han C
GY
Gao Y
ZK
Zhang K
JY
Jiang Y
ZJ
Zhou J
SY
Shao Y
HZ
Hu Z
TY
Tian Y
ZH
Zhang H
DN
Dai N
LL
Liu L
WX
Wu X
ZW
Zhao W
ZX
Zhang X
ZZ
Zang Z
NJ
Nie J
SW
Sun W
ZY
Zhao Y
MY
Mao Y
JP
Jiang P
JH
Ji H
DQ
Dong Q
LJ
Li J
LZ
Li Z
BX
Bai X
LL
Li L
LM
Lin M
DM
Dong M
LJ
Li J
ZP
Zhu P
WC
Wang C
ZY
Zhang Y
JP
Jiang P
WY
Wang Y
JR
Jawed R
XJ
Xu J
ZY
Zhang Y
WQ
Wang Q
YY
Yang Y
YF
Yang F
LM
Lian M
JX
Jiang X
XX
Xiao X
LY
Li Y
FJ
Fang J
QD
Qiu D
ZZ
Zhu Z
QH
Qiu H
ZJ
Zhang J
TW
Tian W
CS
Chen S
JL
Jiang L
JB
Ji B
LP
Li P
CG
Chen G
WT
Wu T
SY
Sun Y
YJ
Yu J
TH
Tang H
HM
He M
XM
Xia M
PH
Pei H
HL
Huang L
QZ
Qing Z
WJ
Wu J
HQ
Huang Q
HJ
Han J
XW
Xie W
SZ
Sun Z
GJ
Guo J
HG
He G
EG
Eric Gershwin M
LZ
Lian Z
LX
Liu X
SM
Seldin MF
LX
Liu X
CW
Chen W
MX
Ma X
Chapter II

Abstract

Summary of the research findings

Primary biliary cholangitis (PBC) is an autoimmune liver disease with a strong hereditary component. Here, we report a genome-wide association study that included 1,122 PBC cases and 4,036 controls of Han Chinese descent, with subsequent replication in a separate cohort of 907 PBC cases and 2,127 controls. Our results show genome-wide association of 14 PBC risk loci including previously identified 6p21 (HLA-DRA and DPB1), 17q12 (ORMDL3), 3q13.33 (CD80), 2q32.3 (STAT1/STAT4), 3q25.33 (IL12A), 4q24 (NF-κB) and 22q13.1 (RPL3/SYNGR1). We also identified variants in IL21, IL21R, CD28/CTLA4/ICOS, CD58, ARID3A and IL16 as novel PBC risk loci. These new findings and histochemical studies showing enhanced expression of IL21 and IL21R in PBC livers (particularly in the hepatic portal tracks) support a disease mechanism in which the deregulation of the IL21 signalling pathway, in addition to CD4 T-cell activation and T-cell co-stimulation are critical components in the development of PBC.

1,122 Han Chinese ancestry cases, 4,036 Han Chinese ancestry controls

Chapter III

Study Statistics

Key metrics and study information

8192
Total Participants
GWAS
Study Type
Yes
Replicated
907 Han Chinese ancestry cases, 2,127 Han Chinese ancestry controls
Replication Participants
East Asian
Ancestry
China
Recruitment Country
Chapter IV

Analysis

Comprehensive review of health and genetic findings

Important Disclaimer: This review has been performed semi-automatically and is provided for informational purposes only. While we strive for accuracy, this analysis may contain errors, omissions, or misinterpretations of the original research. DNA Genics disclaims all liability for any inaccuracies, errors, or consequences arising from the use of this information. Users should independently verify all information and consult original research publications before making any decisions based on this content. This analysis is not intended as a substitute for professional scientific review or medical advice.

Analysis In Progress

Our analysis of this publication is currently being prepared. Please check back soon for comprehensive insights into the health and genetic findings discussed in this research.